ABBV

AbbVie Inc. (ABBV)

Last Price$171.5(1.2%)
Market Cap$303.5B
LTM EPS
$2.89
EPS growth
300.9%
Ben Graham Fair Value
$1,512.7
Undervalued (Ben Graham formula)
781.9%
Stock quality
7/10
Good

ABBV Ben Graham Fair Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

ABBV EPS growth & Dividend Yield

Crunching data... Almost there!

ABBV vs Peer Set: Ben Graham Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for ABBV

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is AbbVie Inc.'s fair value according to the Ben Graham formula?

As of Sep 30, 2024, AbbVie Inc.'s fair value using the Ben Graham formula is $1,512.7 per share. This is calculated using Ben Graham formula, where EPS is $2.9 and BVPS (Book Value Per Share) is $3.4. The current price of $171.5 suggests AbbVie Inc. may be overvalued by this conservative metric.

What is AbbVie Inc. earnings per share (EPS)?

AbbVie Inc. earnings per share (EPS) for the twelve months ending Sep 30, 2024, was $2.9, a 300.9% growth year-over-year.

What is AbbVie Inc.'s margin of safety based on the Ben Graham analysis?

AbbVie Inc.'s margin of safety is positive 781.9%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.